Serene Josiah

709 total citations
25 papers, 485 citations indexed

About

Serene Josiah is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Serene Josiah has authored 25 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Cancer Research. Recurrent topics in Serene Josiah's work include TGF-β signaling in diseases (4 papers), Computational Drug Discovery Methods (3 papers) and Glaucoma and retinal disorders (3 papers). Serene Josiah is often cited by papers focused on TGF-β signaling in diseases (4 papers), Computational Drug Discovery Methods (3 papers) and Glaucoma and retinal disorders (3 papers). Serene Josiah collaborates with scholars based in United States, Greece and United Kingdom. Serene Josiah's co-authors include Scott Bowes, Miki Newman, Leona Ling, Juswinder Singh, Wen‐Cherng Lee, Claudio Chuaqui, P. Ann Boriack‐Sjodin, Hung Kam Cheung, Timothy Pontz and Robert M. Arduini and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Analytical Biochemistry.

In The Last Decade

Serene Josiah

25 papers receiving 465 citations

Peers

Serene Josiah

ONCOL

CTM

PFM

Deborah Moshinsky United States

Olivier Defert Belgium

Vidula Sukhatme United States

Yuzhu Zheng China

Alexander R. Chait United States

John Doran United States

Thomas Schroeter United States

William T. McMillen United States

Jos de Man Netherlands

Scott Bowes United States

Deborah Moshinsky United States

Serene Josiah

270 ×0.8

166 ×2.1

ONCOL

59 ×0.8

CTM

31 ×0.7

24 ×0.6

PFM

Citations per year, relative to Serene Josiah Serene Josiah (= 1×) peers Deborah Moshinsky

Countries citing papers authored by Serene Josiah

Since Specialization

Citations

This map shows the geographic impact of Serene Josiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serene Josiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serene Josiah more than expected).

Fields of papers citing papers by Serene Josiah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serene Josiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serene Josiah. The network helps show where Serene Josiah may publish in the future.

Co-authorship network of co-authors of Serene Josiah

This figure shows the co-authorship network connecting the top 25 collaborators of Serene Josiah. A scholar is included among the top collaborators of Serene Josiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serene Josiah. Serene Josiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Josiah, Serene, et al.. (2024). Abstract 4007: AIC100 CAR-T cells targeting ICAM-1 are efficacious against solid tumors in xenograft mouse models of non-small cell lung cancer (NSCLC) and cervical cancer (CC). Cancer Research. 84(6_Supplement). 4007–4007. 1 indexed citations

Verma, Mayank, Nan Liu, Brian K. Miller, et al.. (2021). VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Molecular Therapy — Methods & Clinical Development. 21. 369–381. 12 indexed citations

Martin, Patrick, et al.. (2020). <p>Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma</p>. Clinical ophthalmology. Volume 14. 885–896. 7 indexed citations

Verma, Mayank, Yuko Shimizu‐Motohashi, Yoko Asakura, et al.. (2019). Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLoS Genetics. 15(12). e1008468–e1008468. 21 indexed citations

Millar, J. Cameron, Anneli Savinainen, Serene Josiah, & Iok-Hou Pang. (2019). Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice. Experimental Eye Research. 188. 107763–107763. 9 indexed citations

Savinainen, Anneli, et al.. (2019). Pharmacokinetics and intraocular pressure–lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey. Experimental Eye Research. 189. 107836–107836. 13 indexed citations

Savinainen, Anneli, et al.. (2018). Reduction of intraocular pressure by SHP639, a novel C-type natriuretic peptide analog, and its exposure in aqueous humor of normotensive Dutch Belted rabbits and beagle dogs. Investigative Ophthalmology & Visual Science. 59(9). 2714–2714. 1 indexed citations

Shen, Manli, Eduardo Eyras, Jie Wu, et al.. (2011). Direct cloning of double-stranded RNAs from RNase protection analysis reveals processing patterns of C/D box snoRNAs and provides evidence for widespread antisense transcript expression. Nucleic Acids Research. 39(22). 9720–9730. 34 indexed citations

Josiah, Serene. (2009). Interpretation of Uniform-Well Readouts. Methods in molecular biology. 486. 177–192. 2 indexed citations

10.

Bonafoux, D., Claudio Chuaqui, P. Ann Boriack‐Sjodin, et al.. (2008). 2-Aminoimidazoles inhibitors of TGF-β receptor 1. Bioorganic & Medicinal Chemistry Letters. 19(3). 912–916. 26 indexed citations

11.

Keefe, Dennis, Donna M. Hess, Socrates J. Tzartos, et al.. (2008). A rapid, fluorescence‐based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines. Cytometry Part B Clinical Cytometry. 76B(3). 206–212. 16 indexed citations

12.

Simons, Peter C., Susan Young, Veronica Gibaja, et al.. (2007). Duplexed, bead‐based competitive assay for inhibitors of protein kinases. Cytometry Part A. 71A(7). 451–459. 5 indexed citations

13.

Bowes, Scott, Dongyu Sun, Chenhui Zeng, et al.. (2006). Quality Assessment and Analysis of Biogen Idec Compound Library. SLAS DISCOVERY. 11(7). 828–835. 13 indexed citations

14.

Sun, Dongyu, Claudio Chuaqui, Zhan Deng, et al.. (2006). A Kinase‐focused Compound Collection: Compilation and Screening Strategy. Chemical Biology & Drug Design. 67(6). 385–394. 14 indexed citations

15.

Sun, Dongyu, Adrian Whitty, Miki Newman, et al.. (2005). Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery. SLAS DISCOVERY. 10(5). 508–516. 15 indexed citations

16.

Newman, Miki & Serene Josiah. (2004). Utilization of Fluorescence Polarization and Time Resolved Fluorescence Resonance Energy Transfer Assay Formats for SAR Studies: Src Kinase as a Model System. SLAS DISCOVERY. 9(6). 525–532. 16 indexed citations

17.

Singh, Juswinder, Claudio Chuaqui, P. Ann Boriack‐Sjodin, et al.. (2003). Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI). Bioorganic & Medicinal Chemistry Letters. 13(24). 4355–4359. 133 indexed citations

18.

Weinreb, Paul H., et al.. (2002). A Cell-Free Electrochemiluminescence Assay for Measuring β1-Integrin–Ligand Interactions. Analytical Biochemistry. 306(2). 305–313. 10 indexed citations

19.

Boisclair, Michael D., et al.. (2000). Development of a Ubiquitin Transfer Assay for High Throughput Screening by Fluorescence Resonance Energy Transfer. SLAS DISCOVERY. 5(5). 319–328. 32 indexed citations

20.

Veals, Susan A., et al.. (1991). Signal transduction pathway activating interferon‐alpha‐stimulated gene expression. British Journal of Haematology. 79(s1). 9–13. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact